Labcorp's Q1 earnings beat expectations, but revenue growth and organic growth trail industry benchmarks.
U.S. consumer confidence plunges to COVID-era low amid tariff concerns, recession fears, and rising costs.
Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
Labcorp's Q1 earnings beat expectations, but revenue growth and organic growth trail industry benchmarks.
U.S. consumer confidence plunges to COVID-era low amid tariff concerns, recession fears, and rising costs.
Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.